Compliance Rate
Compliance Rate
0.0%
Compliant submissions
0
Incompliant submissions
1
Total trials
1
My Organizations' Clinical Trials
Showing 625 of 1949 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/17/15
End: 11/14/22
Due: 11/14/23
Phase: N/A
Priority: Normal
Start: 07/19/19
End: 05/14/20
Due: 05/14/21
Phase: N/A
Priority: Normal
Start: 06/09/20
End: 12/02/21
Due: 12/02/22
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 08/22/18
Due: 08/22/19
Phase: N/A
Priority: Normal
Start: 02/28/18
End: 07/05/22
Due: 07/05/23
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 11/30/11
Due: 11/30/12
Phase: N/A
Priority: Normal
Start: 01/30/18
End: 07/14/21
Due: 07/14/22
Phase: N/A
Priority: Normal
Start: 05/31/07
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 04/30/13
Due: 04/30/14
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 01/31/16
Due: 01/31/17
Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors
Phase: N/A
Priority: Normal
Start: 02/28/93
End: 04/30/01
Due: 04/30/02
Phase: N/A
Priority: Normal
Start: 01/05/23
End: 07/26/24
Due: 07/26/25
Phase: N/A
Priority: Normal
Start: 05/01/23
End: 12/12/23
Due: 12/12/24
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 11/30/14
Due: 11/30/15
Phase: N/A
Priority: Normal
Start: 08/02/17
End: 09/09/20
Due: 09/09/21
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 02/28/24
Due: 02/28/25
Phase: N/A
Priority: Normal
Start: 08/01/18
End: 04/15/24
Due: 04/15/25
Phase: N/A
Priority: Normal
Start: 02/02/24
End: 06/22/24
Due: 06/22/25
Phase: N/A
Priority: Normal
Start: 06/26/17
End: 07/30/18
Due: 07/30/19
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 09/30/16
Due: 09/30/17
Phase: N/A
Priority: Normal
Start: 03/06/25
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 11/30/04
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 05/17/23
End: 03/31/25
Due: 03/31/26
Phase: N/A
Priority: Normal
Start: 02/02/17
End: 04/17/19
Due: 04/17/20